Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 306

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Machine Learning–Based Radiomics for Molecular Subtyping of Gliomas

Open access
Lu, Chia-Feng, Hsu, Fei-Ting, Hsieh, Kevin Li-Chun, Kao, Yu-Chieh Jill, Cheng, Sho-Jen, Hsu, Justin Bo-Kai, Tsai, Ping-Huei, Chen, Ray-Jade, Huang, Chao-Ching, Yen, Yun, Chen, Cheng-Yu·2018·Clinical Cancer Research

Abstract

Purpose: The new classification announced by the World Health Organization in 2016 recognized five molecular subtypes of diffuse gliomas based on isocitrate dehydrogenase (IDH) and 1p/19q genotypes in addition to histologic phenotypes. We aim to determine whether clinical MRI can stratify these molecular subtypes to benefit the diagnosis and monitoring of gliomas. Experimental Design: The data from 456 subjects with gliomas were obtained from The Cancer Imaging Archive. Overall, 214 subjects, including 106 cases of glioblastomas and 108 cases of lower grade gliomas with preoperative MRI, survival data, histology, IDH, and 1p/19q status were included. We proposed a three-level machine-learning model based on multimodal MR radiomics to classify glioma subtypes. An independent dataset with 70 glioma subjects was further collected to verify the model performance. Results: The IDH and 1p/19q status of gliomas can be classified by radiomics and machine-learning approaches, with areas under ROC curves between 0.922 and 0.975 and accuracies between 87.7% and 96.1% estimated on the training dataset. The test on the validation dataset showed a comparable model performance with that on the training dataset, suggesting the efficacy of the trained classifiers. The classification of 5 molecular subtypes solely based on the MR phenotypes achieved an 81.8% accuracy, and a higher accuracy of 89.2% could be achieved if the histology diagnosis is available. Conclusions: The MR radiomics-based method provides a reliable alternative to determine the histology and molecular subtypes of gliomas. Clin Cancer Res; 24(18); 4429–36. ©2018 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-17-3445

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

See all 306

Metadata

Authors
Lu, C.-F., Hsu, F.-T., Hsieh, K. L.-C., Kao, Y.-C. J., Cheng, S.-J., Hsu, J. B.-K., Tsai, P.-H., Chen, R.-J., Huang, C.-C., Yen, Y., & Chen, C.-Y.
Venue
Clinical Cancer Research
Published
2018-09-14
Volume
24
Issue
18
Pages
4429-4436
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2804850886
Cited by
306
References
42
FWCI
23.31
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Machine Learning–Based Radiomics for Molecular Subtyping of Gliomas. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-17-3445
The paper
Lu, C.-F., Hsu, F.-T., Hsieh, K. L.-C., Kao, Y.-C. J., Cheng, S.-J., Hsu, J. B.-K., Tsai, P.-H., Chen, R.-J., Huang, C.-C., Yen, Y., & Chen, C.-Y. (2018). Machine Learning–Based Radiomics for Molecular Subtyping of Gliomas. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-17-3445

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.